Articles
-
1 week ago |
axios.com | Erin Brodwin
Health care AI infrastructure startup Commure raised $200 million in growth financing from General Catalyst's "customer value fund," a vehicle GC created to power companies' sales and marketing budgets. Why it matters: The structure means Commure must tie financing to customer performance rather than equity — a notable move for GC, which poured millions into now-shuttered AI health infrastructure play Olive. What's next: CEO Tanay Tandon expects to see Commure go public in the next two years.
-
1 week ago |
axios.com | Erin Brodwin
Virtual physical therapy provider Sword Health raised $40 million at a $4 billion valuation in a round led by General Catalyst. Why it matters: All eyes are on the next digital health company to go public, and Sword has a strapping comparative in Hinge, seen as the category leader in virtual PT. Yes, but: Sword, which is cashflow positive on an annual basis, has no imminent plans to file an S-1, CEO Virgilio Bento tells Axios. Bento sees the company going public in the next five years.
-
2 weeks ago |
axios.com | Erin Brodwin
The DispatchHealth-Medically Home merger closed last week, and a leaked 498-page document detailing the terms suggests a dramatic loss in valuation for Medically Home. Why it matters: Unprofitable players in the hospital-at-home sector face vanishing runway and rising investor demands. What's inside: The entire merger document, titled Project Peregrine, was accidentally sent on March 22 in a mass email to Medically Home employees, per the three sources, one of whom shared the document with Axios.
-
2 weeks ago |
axios.com | Erin Brodwin |Claire Rychlewski
Autonomize AI, a provider of AI agents to health systems and plans, raised $28 million in Series A funding, CEO Ganesh Padmanabhan tells Axios exclusively. The big picture: It's the latest sign of investor appetite for infrastructure-layer AI in health care — especially platforms that promise scale, compliance, and a clear ROI. Follow the money: Autonomize plans to expand deployment of its "Copilot" AI agents across payers, providers, and life sciences organizations.
-
2 weeks ago |
axios.com | Erin Brodwin
Axios Pro Exclusive ContentIllustration: Aïda Amer/AxiosHealth benefits provider Zorro raised $20 million in Series A funding led by Entrée Capital, CEO Guy Ezekiel tells Axios exclusively. Why it matters: As employers wrestle with rising health plan costs, individual coverage health reimbursement arrangements (ICHRAs) are gaining steam.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 16K
- Tweets
- 9
- DMs Open
- No
Friday scoop: The DispatchHealth-Medically Home merger closed last week, and a leaked 498-page document detailing the terms suggests a dramatic loss in valuation for Medically Home. https://t.co/2uBD4OoSMb
Omada's stock has been plummeting. Issues we knew about: Moderate (not massive) growth, low margins, and lots of customer concentration. Still, analysts — and seemingly everyone else — was incredibly optimistic for success. So, what happened? https://t.co/MjciYOmVeo
yes, these issues are things we've reported on heavily, but even given those problems, many analysts were bullish on success...
@erinbrodwin It was way overpriced at listing. I’d call this a correction. Moderate growth, low margins, mega customer concentration (Cigna >50% of revenue), undifferentiated product. It sounds harsh but it’s reality. This is where it should be valued.